Mycoplasma pneumoniae is the only known Mycoplasma species that is a primary pathogen
in man. Clinical manifestations can range from asymptomatic respiratory infections
to severe pneumonia. M. pneumoniae accounts for 15 to 20% of total pneumonia.
ImmunoWELL Mycoplasma pneumoniae IgM kit is the first commercial IgM enzyme
immunoassay (EIA) product providing single specimen acute diseases serodiagnosis.
The ImmunoWELL Mycoplasma pneumoniae kits are the worldwide market leading products
and the only products detecting specific IgM or IgG antibodies to the 'gold standard'
complement fixation antigen. Other products on the market use detergent extracted
protein and not the complement fixation glycoprotein as source antigen.
Only the IgM test result is required for M. pneumoniae serodiagnosis. Most
laboratories still concurrently test both IgG and IgM with the ImmunoWELL test
kits, and high IgG reactivity is often used as supplemental evidence for current
infection. However, IgG results alone (any method or test kit) do not accurately
predict active infection unless paired sera (acute and convalescent specimens)
are tested at one time.
ImmunoFLOW Mycoplasma, detecting the same complement-fixing IgM antibodies measured
using GenBio's reference ImmunoWELL tests is now available. (Not available within
the U.S. yet). ImmunoFLOW is an easy-to-use, visually interpreted, and rapid test.
It require no special equipment. ImmunoFLOW is ideal for:
- Situations where rapid patient results are important
- Small and medium-sized hospitals
- Group practice office laboratories
- Anywhere that instrumentation may be difficult
- High humidity environments that may affect lateral flow method results
- Areas where refrigeration storage is limited